Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nīmes
Secondary objectives include:
* Determine the intrinsic properties essential for the dissemination and chemoresistance of these cells capable of initiating tumors
* Identify a "molecular signature" for potential invasiveness and chemoresistance of cells initiating metastases.
* Describe the evolution of patients during 24 months of follow up and correlations with observed cellular profiles.
* Enrich the tumor bank of the institution.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient must have given his/her informed and signed consent
The patient must be insured or beneficiary of a health insurance plan
Patient with adenocarcinoma-type colorectal cancer:
stage III at diagnosis, surgical resection of the primary tumor proposed.
stage IV at diagnosis, surgical resection of the primary tumor and possibly of metastases proposed.
Stage IV who have already undergone surgical excision of the primary tumor, and for whom metastasectomy is now proposed.
You may not be if
The patient is participating in another study
The patient is in an exclusion period determined by a previous study
The patient is under judicial protection, under tutorship or curatorship
The patient refuses to sign the consent
It is impossible to correctly inform the patient
Patients for whom surgical resection of the primary tumor is not considered as an option
PStage IV at diagnosis, but metastasectomy is not considered as an option
Patients with positive HIV, Hepatitis B or Hepatitis C serology
Clareo Health | Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer
